Uterine rupture with the use of vaginal prostaglandin E2.
D015232:Dinoprostone; D005260:Female; D006801:Humans; D007751:Labor, Induced; D011247:Pregnancy; D011458:Prostaglandins E / Q000008:administration & dosage / Q000009:adverse effects*; D013488:Suppositories; D014597:Uterine Rupture / Q000139:chemically induced*
D011458:Prostaglandins E; D013488:Suppositories; D015232:Dinoprostone